Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive pharmacological and experimental study of Ginsenoside Re as a potential therapeutic agent for non-alcoholic fatty liver disease

Published:2024-08 Issue: Volume:177 Page:116955
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhang Jinshan^ORCID,Duan Mingfei,Wu Shaohong,Jiang Shan,Hu Songhao,Chen Wenhui,Zhang Junchang,Quan Haiyan,Yang Wah^ORCID,Wang Cunchuan

Funder

Jilin Provincial Natural Science Foundation

Publisher

Elsevier BV

Reference42 articles.

1. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis;Riazi;Lancet Gastroenterol. Hepatol.,2022

2. Hepatic lipid metabolism and non-alcoholic fatty liver disease[J];Tessari;Nutr., Metab. Cardiovasc. Dis.,2009

3. The liver as an endocrine organ—linking NAFLD and insulin resistance[J];Watt;Endocr. Rev.,2019

4. Innate immunity and inflammation in NAFLD/NASH[J];Arrese;Dig. Dis. Sci.,2016

5. Genetic and epigenetic regulation in nonalcoholic fatty liver disease (NAFLD)[J];Del Campo;Int. J. Mol. Sci.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP